biote OverviewLatest common stock for BTMD: $4K.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
The latest common stock for BTMD is $4K as of June 2026. That compares with $3K in the prior-year period — up 33.3% year over year. Investors often review this figure alongside biote's historical trend and sector peers before judging valuation or financial health.
Over the past year, BTMD's common stock moved from $3K to $4K — a 33.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in biote's operating scale or balance-sheet position.
A common stock figure of $4K for BTMD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting BTMD's common stock ($4K), review year-over-year change from $3K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
